mous
hepat
viru
mhv
provid
excel
anim
model
studi
immunopatholog
mechan
involv
hepat
viral
diseas
previous
gener
attenu
viral
variant
induc
subclin
diseas
recoveri
within
day
contrast
strain
induc
develop
fulmin
hepat
lead
death
within
day
paper
document
intrahepat
splenic
cell
subpopul
involv
hepat
process
viral
elimin
identifi
attenu
pathogen
mice
percentag
intrahepat
cell
decreas
attenu
mice
increas
mice
infect
pathogen
compar
uninfect
anim
moreov
mice
percentag
intrahepat
cell
slightli
decreas
h
pi
increas
day
pi
contrast
ratio
splenic
lymphoid
subpopul
increas
first
day
infect
return
normal
valu
day
pi
intrahepat
result
indic
attenu
phenotyp
viru
relat
two
differ
mechan
first
involv
increas
intrahepat
tcr
inter
nkt
cell
second
favor
recruit
activ
cell
liver
result
discuss
relat
integr
intrahepat
immun
toler
mechan
immunemedi
viral
elimin
hepat
inflammatori
diseas
induc
variou
caus
one
viral
infect
lymphocyt
assum
play
essenti
role
host
immun
respons
tissu
injuri
elimin
viral
infect
incapac
host
elimin
viral
infect
favor
develop
acut
chronic
hepat
seen
human
viral
hepatitid
b
c
howev
role
specif
intrahepat
lymphoid
subset
involv
simultan
immun
respons
viral
infect
intrahepat
immun
toler
may
disturb
effici
immunemedi
viral
elimin
mechan
decreas
intens
tcellmedi
immun
pathway
mous
hepat
viru
mhv
infect
provid
excel
anim
model
studi
immunemedi
mechan
involv
intrahepat
viral
elimin
hepatotrop
serotyp
liver
main
target
organ
viral
replic
suscept
mous
pathogen
mice
develop
acut
hepat
die
within
day
within
time
progress
necrot
lesion
observ
liver
induc
dysfunct
due
extens
necrosi
simultan
immun
disord
occur
variou
lymphoid
organ
lead
cellular
humor
immunodefici
previous
gener
viral
variant
induc
subclin
infect
involv
hepat
cellular
lesion
mice
viral
clearanc
occur
within
day
postinfect
pi
induc
immunodefici
observ
pathogen
infect
mice
howev
mechan
involv
attenu
liver
pathogen
variant
yet
elucid
hepat
sinusoid
normal
adult
mice
contain
tcr
cell
receptor
cell
appear
distinct
cell
found
peripher
lymphoid
tissu
cell
character
tcr
intermedi
intens
tcr
inter
consist
doubl
neg
singl
posit
cell
percentag
singleposit
cell
report
higher
liver
spleen
thymu
moreov
lymphocyt
express
higher
level
leucocyt
function
express
cell
surfac
marker
normal
found
antigenexperienc
cell
tcr
inter
cell
subset
express
natur
killer
nk
molecul
defin
nkt
cell
protect
role
intrahepat
cell
subset
contradictori
demonstr
intrahepat
tcr
inter
cell
account
protect
mechan
hepat
resist
earli
phase
murin
salmonellosi
contrast
downregul
tcr
inter
cell
favor
develop
protect
immun
listeriosi
bacteri
clearanc
thu
mediat
cytotox
cell
inform
avail
protect
role
cell
viral
hepat
previous
observ
infect
suscept
mice
pathogen
strain
induc
increas
total
number
intrahepat
mononuclear
cell
mnc
ratio
acut
hepat
moreov
hepat
tcr
inter
high
tcr
high
high
cell
increas
studi
activ
marker
suggest
hepat
tcr
inter
high
cell
may
activ
situ
viral
hepat
abl
control
viral
infect
suggest
protect
viral
infect
thu
use
attenu
viru
induc
subclin
infect
without
extens
hepat
lesion
may
use
elucid
phenotyp
protect
intrahepat
cell
subpopul
paper
report
hepat
splenic
cell
subpopul
viral
infect
induc
attenu
variant
suscept
mice
result
indic
attenu
phenotyp
viru
relat
two
differ
mechan
first
involv
absenc
intrahepat
tcr
inter
nkt
cell
activ
second
favor
recruit
activ
cell
liver
mice
purchas
jackson
laboratori
bar
harbor
prior
experiment
anim
test
presenc
antimhv
antibodi
elisa
test
use
prepar
antigen
experiment
anim
hous
steril
atmospher
forma
scientif
marietta
oh
femal
mice
week
age
use
experi
pathogen
clone
substrain
isol
liver
infect
mice
passag
two
four
time
cell
attenu
clone
substrain
produc
cell
previous
describ
virus
passag
cell
use
pathogen
properti
test
regularli
vivo
viral
infect
group
three
mice
infect
intraperiton
ip
tcid
pathogen
attenu
variant
mockinfect
mice
receiv
ip
similar
volum
pb
variou
time
pi
mice
anesthet
ketamin
sulphat
mgkg
xylazin
mgkg
ip
inject
mice
bled
section
portal
vein
aortic
arteri
describ
watanab
et
al
liver
spleen
harvest
follow
exsanguin
cell
continu
mous
fibroblast
cell
line
grown
dulbecco
mem
glutamin
mm
fetal
calf
serum
fc
antibiot
penicillin
uml
streptomycin
mgml
gibco
brl
grand
island
ny
cell
use
viru
product
titrat
splenic
lymphocyt
obtain
three
mice
experiment
group
spleen
press
cell
strainer
falcon
fisher
scientif
co
canada
cold
rpmi
supplement
fc
gibco
lymphocyt
enrich
passag
lymphoprep
gradient
cedarlan
hornbi
ontario
canada
cell
suspens
centrifug
resuspend
ml
rpmi
fc
electron
count
coulter
counter
coulter
electron
hialeah
fl
cell
viabil
rang
assay
trypan
blue
exclus
liver
three
mice
experiment
group
press
cell
strainer
obtain
mnc
cell
wash
ml
rpmi
gibco
contain
fc
antibiot
cell
suspens
pool
underlaid
ml
fc
allow
debri
sediment
top
layer
centrifug
top
discontinu
percol
gradient
percol
pb
ersham
pharmacia
uppsala
sweden
min
mnc
collect
interfac
percol
layer
cell
wash
rpmi
contain
fc
electron
count
describ
deplet
cell
hepat
splenic
cell
done
incub
cell
antibodi
monoclon
antibodi
mab
pharmingen
san
diego
ca
guinea
pig
complement
cedarlan
residu
cell
phenotyp
h
later
describ
mnc
isol
liver
origin
group
mice
describ
pool
togeth
cell
seed
plate
concentr
cellsml
infect
moi
virus
plate
incub
co
atmospher
h
cell
supernat
collect
electron
count
immunolabel
cytofluorometr
studi
liver
infect
mice
collect
rpmi
frozen
thaw
centrifug
supernat
use
viral
suspens
serial
dilut
step
dulbecco
mem
test
cell
cultur
microtit
plate
cytopath
effect
character
syncytia
format
cell
lysi
record
h
pi
viru
titer
express
log
tcid
titrat
perform
triplic
cell
subpopul
label
follow
mab
fluorescein
isothiocyanateconjug
fitc
mab
pharmingen
phycoerythrineconjug
pec
mab
pharmingen
clone
pharmingen
fitcor
pecantitcr
clone
pharmingen
clone
pharmingen
clone
pharmingen
clone
pharmingen
cell
suspens
prepar
spleen
cell
incub
optim
concentr
mab
min
wash
pb
contain
fc
fix
overnight
pb
ph
contain
formaldehyd
fisher
scientif
hepat
mnc
isol
cell
incub
optim
concentr
mab
describ
splenic
cell
hepat
splenic
cell
similarli
doubl
label
follow
marker
tcr
tcr
tcr
tcr
isotyp
control
correspond
conjug
antibodi
use
cytofluorometr
analys
perform
facscan
bectondickinson
mountain
view
ca
cytofluoromet
cell
quest
softwar
bectondickinson
gate
perform
accord
forward
scatter
fsc
versu
scatter
ssc
paramet
select
distinct
lymphoid
cell
popul
ten
thousand
cell
select
gate
analyz
per
sampl
percentag
variou
subpopul
determin
multiparametr
analysi
experi
conduct
triplic
experi
data
record
pool
three
liver
metabol
activ
intrahepat
splenic
mnc
evalu
tetrazolium
salt
reduct
test
promega
madison
wi
mnc
seed
per
well
vol
flatbottom
microtit
plate
rpmi
contain
fc
mercaptoethanol
antibiot
cell
treat
optim
concentr
phytohemagglutinin
pha
concanavalin
con
sigmaaldrich
oakvil
ontario
canada
variou
time
incub
mt
phenazin
methosulf
pm
promega
ad
cell
incub
h
optic
densiti
determin
use
elisa
reader
filter
molecular
devic
sunnyval
ca
experi
conduct
quadrupl
percentag
absolut
number
od
evalu
student
test
compar
cell
infect
control
mice
vivo
studi
compar
infect
cell
control
cell
vitro
studi
ratio
analyz
use
wilcoxonmannwithney
u
test
previous
demonstr
attenu
variant
induc
subclin
hepat
character
inflammatori
foci
accompani
perivascular
infiltr
mononuclear
cell
recoveri
observ
within
day
pi
order
verifi
effici
immunemedi
recoveri
infect
vs
intrahepat
high
tion
mechan
replic
hepat
viral
titer
yacand
mice
compar
variou
time
pi
mice
viral
titer
reach
maximum
day
pi
tcid
ml
decreas
within
day
pi
viral
titer
reach
higher
level
pathogen
mice
death
day
pi
tcid
ml
identifi
intrahepat
cell
subset
involv
control
viral
infect
mice
group
three
mice
infect
pathogen
attenu
variant
mice
sacrif
day
pi
intrahepat
splenic
lymphoid
cell
isol
number
lymphoid
cell
per
liver
determin
electron
count
number
intrahepat
mononuclear
cell
isol
mice
cellsliv
similar
uninfect
mice
cell
liver
moreov
previouli
observ
increas
intrahepat
mononuclear
cell
observ
mice
cellsliv
p
verifi
splenic
intrahepat
lymphocyt
subset
modifi
pathogen
attenu
mice
percentag
cell
phenotyp
doubl
immunolabel
shown
tabl
percentag
cell
increas
mice
infect
pathogen
decreas
attenu
mice
p
howev
percentag
cell
slightli
increas
infect
mous
group
p
signific
differ
percentag
cell
evidenc
spleen
infect
mice
group
previous
demonstr
intrahepat
tcr
inter
cell
express
high
level
molecul
increas
mice
determin
increas
tcr
inter
cell
associ
viral
pathogen
intrahepat
lymphoid
cell
attenu
pathogen
mice
cell
isol
three
day
pi
doublelabel
tcr
antibodi
shown
fig
intrahepat
tcr
inter
tcr
inter
cell
percentag
decreas
mice
p
p
increas
mice
p
p
spleen
howev
chang
detect
tcr
inter
subpopul
tcr
high
cell
percentag
decreas
mice
p
fig
intrahepat
cell
subset
express
intermedi
level
tcr
may
separ
subset
group
depend
presenc
surfac
marker
nk
determin
phenotyp
tcr
inter
cell
liver
infect
mice
doubl
immunolabel
tcr
antibodi
perform
intrahepat
lymphoid
cell
isol
pathogen
mice
day
pi
shown
fig
intrahepat
tcr
inter
cell
percentag
decreas
mice
p
increas
mice
p
addit
tcr
high
cell
percentag
increas
mice
p
howev
splenic
tcr
high
tcr
high
cell
percentag
decreas
mice
p
p
fig
hand
percentag
intrahepat
tcr
inter
cell
decreas
group
infect
mice
p
tcr
cell
affect
fig
addit
intrahepat
tcr
inter
cell
increas
order
identifi
sequenti
evolut
intrahepat
cell
subset
favor
recoveri
group
three
mice
infect
attenu
viru
sacrif
h
day
pi
number
intrahepat
mnc
record
cell
subpopul
analyz
follow
doubl
immunolabel
marker
signific
increas
number
intrahepat
mnc
observ
subclin
infect
day
pi
shown
fig
percentag
cell
transient
decreas
first
h
pi
follow
percentag
increas
day
pi
howev
cell
slightli
decreas
h
pi
strongli
increas
day
pi
percentag
increas
singleposit
cell
remain
higher
cell
chang
subpopul
evid
ratio
analysi
tabl
intrahepat
ratio
verifi
whether
decreas
tcr
inter
high
cell
observ
attenu
mice
favor
subclin
infect
recoveri
follow
attenu
infect
mice
infect
viru
tcr
profil
cell
conduct
variou
time
pi
shown
fig
tcr
high
tcr
inter
cell
percentag
decreas
first
day
viral
infect
addit
percentag
tcr
inter
high
cell
increas
day
pi
suggest
recruit
activ
cell
subset
similarli
verifi
whether
decreas
specif
intrahepat
tcr
inter
high
cell
subset
favor
subclin
infect
mnc
isol
liver
group
three
mice
doubl
immunolabel
tcr
antibodi
observ
fig
intrahepat
tcr
inter
cell
control
mice
express
high
level
cell
tcr
high
cell
express
lower
level
low
molecul
mice
tcr
inter
cell
transient
decreas
two
day
pi
fig
return
normal
valu
thereaft
fig
hand
tcr
inter
low
tcr
high
low
cell
increas
first
day
pi
also
tcr
inter
low
cell
remain
higher
day
pi
fig
major
increas
tcr
high
cell
observ
liver
infect
mice
previous
observ
intrahepat
tcr
inter
high
cell
isol
pathogen
mice
also
express
activ
marker
postul
infect
attenu
variant
allow
activ
tcr
inter
high
cell
subset
hypothesi
verifi
doubl
immunolabel
activ
marker
intrahepat
lymphoid
cell
isol
attenu
mice
import
increas
intrahepat
cell
intrahepat
splenic
mnc
doubl
label
antibodi
analyz
use
facscan
cytofluoromet
lymphoid
cell
gate
accord
fsc
ssc
paramet
number
cell
evalu
base
total
event
record
experi
conduct
triplic
p
p
observ
mice
except
intrahepat
tcr
high
cell
p
compar
control
mice
splenic
tcr
inter
cell
slightli
decreas
mice
control
mice
p
decreas
tcr
inter
cell
mice
control
mice
p
differ
observ
percentag
hepat
splenic
tcr
high
inter
cell
addit
signific
differ
found
intrahepat
splenic
total
subset
day
pi
result
shown
order
verifi
whether
intrahepat
mnc
mice
abl
respond
antigen
stimul
intrahepat
splenic
lymphoid
cell
isol
mice
day
pi
mice
day
pi
cell
stimul
pha
con
level
blastic
transform
evalu
colorimetr
method
base
tetrazolium
salt
reduct
result
shown
fig
indic
intrahepat
lymphoid
cell
isol
mice
total
anerg
day
pi
mice
less
activ
cell
uninfect
mice
fig
p
day
pi
cell
activ
con
pha
greater
intrahepat
lymphoid
cell
mice
control
group
fig
p
howev
splenic
lymphoid
cell
mice
day
retain
abil
respond
con
pha
stimul
activ
level
splenic
cell
higher
cell
mice
three
day
pi
p
p
fig
determin
phenotyp
partial
total
anerg
intrahepat
lymphoid
cell
mice
respect
lymphoid
cell
isol
liver
spleen
group
virusinfect
mice
day
pi
subsequ
cell
deplet
cytotox
use
antibodi
complement
doubl
immunolabel
residu
cell
reveal
less
express
marker
cell
cultur
h
metabol
activ
residu
cell
evalu
reduct
level
tetrazolium
salt
shown
fig
metabol
activ
intrahepat
cell
control
mice
partial
decreas
cell
remov
p
howev
decreas
exacerb
intrahepat
cell
mice
p
fig
addit
metabol
activ
intrahepat
lymphoid
cell
deplet
depress
mice
p
fig
howev
decreas
remov
cell
less
evid
splenic
cell
isol
group
infect
mice
fig
result
indic
cell
subset
contribut
mainli
metabol
activ
total
intrahepat
lymphoid
cell
isol
mice
henc
cell
subset
anerg
mice
subset
anerg
mice
determin
role
viral
infect
modul
intrahepat
subset
observ
mice
intrahepat
lymphoid
cell
isol
infect
vitro
virus
h
subset
discrimin
doubl
immunolabel
tcr
antibodi
shown
fig
viru
induc
signific
alter
subset
vitro
infect
intrahepat
lymphoid
cell
howev
cell
deplet
cytotox
antibodi
complement
tcr
inter
cell
percentag
increas
cell
p
fig
increas
higher
cell
cell
deplet
p
addit
tcr
high
cell
slightli
increas
cell
decreas
cell
p
analysi
absolut
number
cell
subset
reveal
rel
percentag
increas
tcr
high
cell
observ
control
infect
cell
reflect
deplet
tcr
high
cell
rather
specif
increas
tcr
high
cell
result
shown
paper
report
subclin
hepat
induc
attenu
variant
relat
low
activ
intrahepat
subset
despit
presenc
viral
replic
liver
first
day
infect
recruit
cell
favor
viral
elimin
within
day
pi
suppress
intrahepat
tcr
inter
cell
mice
infect
attenu
viru
support
mani
observ
first
intrahepat
lymphoid
cell
increas
mice
contrast
increas
ob
second
percentag
intrahepat
tcr
inter
tcr
high
cell
decreas
mice
increas
pathogen
mice
moreov
tcr
inter
high
high
subset
increas
first
day
infect
viru
observ
mice
addit
cell
subset
normal
found
activ
prolifer
intrahepat
lymphoid
cell
increas
attenu
mice
final
intrahepat
lymphoid
cell
isol
mice
could
stimul
lectin
role
anerg
intrahepat
cell
subset
hepat
process
may
evalu
regard
phenotyp
chang
intrahepat
lymphoid
cell
pathogen
mice
decreas
intrahepat
nkt
cell
subset
group
infect
mice
suggest
cell
subset
play
major
role
viral
elimin
previous
shown
intrahepat
tcr
inter
high
high
increas
acut
hepat
induc
pathogen
viru
work
demonstr
attenu
mice
intrahepat
tcr
inter
high
cell
transient
decreas
addit
cell
anerg
sinc
partial
stimul
intrahepat
lymphoid
cell
mice
mainli
due
cell
rather
cell
subset
phenomenon
occur
spleen
suggest
specif
intrahepat
mechan
occur
first
day
infect
lead
blockad
matur
process
induct
suppress
state
intrahepat
tcr
inter
cell
compar
seen
immun
toler
immun
toler
may
due
unrespons
resid
lymphocyt
despit
antigen
pre
sentat
activ
cytokin
product
unrespons
intrahepat
lymphocyt
may
result
sever
mechan
propos
autocrin
loop
initi
interact
beween
lymphocyt
kupffer
cell
caus
activ
product
turn
may
induc
releas
kupffer
cell
suppress
cell
prolifer
kupffer
cell
import
target
pathogen
replic
liver
suggest
propos
mechan
would
alter
viral
infect
replic
lower
macrophag
produc
pathogen
infect
suggest
toler
control
kupffer
cell
would
disturb
mice
moreov
product
tumor
necrosi
prostaglandin
kupffer
cell
could
also
respons
decreas
prolif
respons
hepat
cell
vivo
treatment
attenu
mice
inhibitor
indomethacin
increas
hepat
sever
percentag
intrahepat
activ
tcr
inter
high
high
cell
result
shown
suggest
suppress
lymphocyt
control
addit
nkt
cell
known
high
produc
favor
stimul
cell
product
cytokin
involv
suppress
respons
seen
immun
toler
sinc
nkt
cell
decreas
liver
infect
group
mice
specul
decreas
cytokin
favor
activ
cell
group
infect
mice
howev
mechan
may
partial
explain
activ
intrahepat
cell
subset
observ
mice
support
decreas
cell
subset
mice
addit
belong
phenotyp
nk
cell
produc
turn
abl
control
viral
replic
preliminari
vitro
experi
suggest
contrast
viru
variant
replic
presenc
liver
could
elimin
site
activ
lymphocyt
suggest
increas
apoptot
liverresid
lymphocyt
follow
antigen
stimul
local
hepat
sinusoid
foci
degen
hepatocyt
caus
lymphocytethrombiinduc
ischemia
signific
increas
apoptot
cell
detect
tunel
test
intrahepat
lymphoid
cell
isol
mice
result
shown
suggest
anergi
observ
cell
soon
day
pi
due
increas
activ
lymphoid
cell
recruit
peripher
immun
organ
situ
cytokinedepriv
suppress
contrast
organ
leukocyt
adhes
intrahepat
endotheli
cell
ec
requir
express
selectin
depend
upon
endotheli
express
vascular
adhes
protein
surfac
molecul
addit
number
leucocyt
adher
intrahepat
ec
control
leucocyteec
interact
remain
constant
even
total
number
circul
leukocyt
vari
time
howev
ec
import
target
pathogen
replic
attenu
viral
strain
cytokin
prostanoid
releas
kupffer
cell
downregul
leukocyt
adhes
intrahepat
ec
decreas
surfac
express
avoid
recruit
lymphoid
cell
immunemedi
liver
damag
antigen
portal
venou
blood
observ
concern
number
intrahepat
lymphoid
cell
attenu
mice
support
hypothesi
integr
intrahepat
ec
essenti
avoid
recrut
andor
activ
lymphocyt
involv
hepat
process
hand
higher
express
molecul
intrahepat
tcr
inter
cell
may
favor
bind
lymphocyt
hepat
cell
express
high
level
specul
suppress
tcr
inter
high
cell
seen
mice
favor
downregul
express
hepatocyt
impair
product
cytokin
cell
thu
avoid
bind
cytotox
cell
hepatocyt
decreas
cell
express
high
level
would
also
protect
destruct
ec
barrier
avoid
exposur
underli
hepatocyt
attack
cytotox
cell
hypothesi
support
fact
intrahepat
cell
subset
stimul
mitogen
intrahepat
lymphoid
cell
attenu
mice
express
activ
marker
mechan
previouli
demonstr
model
con
ainduc
hepat
fulmin
diseas
mediat
activ
lymphocyt
follow
contact
hepatocytebound
con
situat
hepat
toler
may
broken
tissu
damag
may
result
action
cell
activ
liver
microenviron
previous
condit
microbi
infect
work
also
observ
intrahepat
cell
anerg
may
act
protect
cell
favor
viral
elimin
protect
role
intrahepat
cell
report
hepat
induc
listeria
monocytogen
adopt
transfer
splenic
cell
alon
exacerb
diseas
bacteri
clearanc
mediat
cytotox
cell
percentag
increas
intrahepat
cell
observ
mice
may
result
either
situ
stimul
intrahepat
resid
cell
recruit
circul
lymphocyt
fact
percentag
cell
transient
decreas
liver
splenic
cell
increas
indic
peripher
stimul
splenic
cell
occur
increas
intrahepat
cell
increas
intrahepat
cell
subset
express
lower
level
antigen
observ
splenic
cell
suggest
intrahepat
cell
recruit
blood
howev
recruit
cell
requir
may
major
intrahepat
vascular
disord
induc
viral
infect
demonstr
pathogen
infect
thu
postul
attenu
infect
liver
involv
intravascular
coagul
demonstr
nonextens
patholog
damag
perivascular
lymphoid
cell
thu
enabl
recruit
circul
activ
cell
hypothesi
also
support
observ
lower
level
cell
strong
anergi
observ
ex
vivo
lectinstimul
intrahepat
lymphoid
cell
mice
interestingli
vitro
infect
intrahepat
lymphoid
cell
reveal
intrahepat
tcr
inter
high
cell
subset
increas
cell
deplet
suggest
cell
may
prevent
activ
cell
subset
howev
deplet
cell
intrahepat
lymphoid
cell
provok
strong
increas
subset
indic
increas
cell
subset
depend
pathogen
properti
viru
strain
absenc
cell
conclud
attenu
phenotyp
variant
relat
recruit
cytototox
cell
produc
peripher
lymphoid
organ
spleen
allow
elimin
infect
cell
liver
without
break
hepat
immun
toler
mechan
work
progress
identifi
viral
mediat
cell
dysfunct
involv
breakdown
toler
mechan
induc
infect
recruit
peripher
cell
mice
